177 related articles for article (PubMed ID: 27254276)
21. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.
Park JW; Zhao L; Cheng SY
Am J Cancer Res; 2013; 3(3):302-11. PubMed ID: 23841029
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
[TBL] [Abstract][Full Text] [Related]
25. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
[TBL] [Abstract][Full Text] [Related]
26. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.
Joseph B; Ji M; Liu D; Hou P; Xing M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173
[TBL] [Abstract][Full Text] [Related]
27. Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.
Lu C; Cheng SY
Steroids; 2011 Aug; 76(9):885-91. PubMed ID: 21473875
[TBL] [Abstract][Full Text] [Related]
28. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
30. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.
Furuya F; Hanover JA; Cheng SY
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1780-5. PubMed ID: 16446424
[TBL] [Abstract][Full Text] [Related]
31. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
Lu C; Zhu X; Willingham MC; Cheng SY
Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
[TBL] [Abstract][Full Text] [Related]
32. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta.
O'Shea PJ; Bassett JH; Sriskantharajah S; Ying H; Cheng SY; Williams GR
Mol Endocrinol; 2005 Dec; 19(12):3045-59. PubMed ID: 16051666
[TBL] [Abstract][Full Text] [Related]
33. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
[TBL] [Abstract][Full Text] [Related]
35. Cardiac glucose utilization in mice with mutated alpha- and beta-thyroid hormone receptors.
Esaki T; Suzuki H; Cook M; Shimoji K; Cheng SY; Sokoloff L; Nunez J
Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1149-53. PubMed ID: 15304375
[TBL] [Abstract][Full Text] [Related]
36. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.
Furuya F; Guigon CJ; Zhao L; Lu C; Hanover JA; Cheng SY
Mol Cell Biol; 2007 Sep; 27(17):6116-26. PubMed ID: 17606624
[TBL] [Abstract][Full Text] [Related]
37. Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription.
Furuya F; Ying H; Zhao L; Cheng SY
Steroids; 2007 Feb; 72(2):171-9. PubMed ID: 17169389
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
39. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.
Furuya F; Lu C; Guigon CJ; Cheng SY
Steroids; 2009 Jul; 74(7):628-34. PubMed ID: 19014961
[TBL] [Abstract][Full Text] [Related]
40. The targeted inactivation of TRβ gene in thyroid follicular cells suggests a new mechanism of regulation of thyroid hormone production.
Selmi-Ruby S; Bouazza L; Obregon MJ; Conscience A; Flamant F; Samarut J; Borson-Chazot F; Rousset B
Endocrinology; 2014 Feb; 155(2):635-46. PubMed ID: 24265449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
